Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medicure (MCUJF) Net Margin (2016 - 2025)

Medicure has reported Net Margin over the past 17 years, most recently at 49.41% for Q4 2025.

  • For Q4 2025, Net Margin fell 4410.0% year-over-year to 49.41%; the TTM value through Dec 2025 reached 23.51%, down 1990.0%, while the annual FY2025 figure was 24.6%, 1985.0% down from the prior year.
  • Net Margin for Q4 2025 was 49.41% at Medicure, down from 15.57% in the prior quarter.
  • Over five years, Net Margin peaked at 27.21% in Q4 2021 and troughed at 49.41% in Q4 2025.
  • A 5-year average of 4.12% and a median of 2.21% in 2024 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: surged 21049bps in 2021 and later tumbled -4410bps in 2025.
  • Year by year, Net Margin stood at 27.21% in 2021, then crashed by -74bps to 7.19% in 2022, then tumbled by -441bps to 24.53% in 2023, then skyrocketed by 78bps to 5.31% in 2024, then tumbled by -831bps to 49.41% in 2025.
  • Business Quant data shows Net Margin for MCUJF at 49.41% in Q4 2025, 15.57% in Q3 2025, and 10.05% in Q2 2025.